Literature DB >> 12571528

New Centers for Disease Control and Prevention's guidelines on HIV counseling and testing for the general population and pregnant women.

Kathryn A Phillips1, Ronald Bayer, James L Chen.   

Abstract

We review two new HIV counseling and testing guidelines by the U.S. Centers for Disease Control and Prevention. The guidelines, which address the general population and pregnant women, reflect an important shift in the goals and methods of counseling and testing that has widespread implications. The guidelines' defining characteristic is the greater emphasis on increasing the numbers of people knowing their HIV status while maintaining the historical focus on extensive pretest counseling and consent procedures. We discuss the policy and practice implications by evaluating five factors: 1) Will the guidelines be adopted? 2) Will at-risk and infected individuals be identified for counseling and testing? 3) Will health care providers offer counseling and testing and patients accept counseling and testing, obtain their test results, seek treatment, and change risky behaviors? 4) Will the guidelines be relatively cost-effective? 5) Will the guidelines be compatible with ethical standards?

Entities:  

Mesh:

Year:  2003        PMID: 12571528     DOI: 10.1097/00126334-200302010-00010

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  2 in total

1.  Correlates of HIV infection among incarcerated women: implications for improving detection of HIV infection.

Authors:  Frederick L Altice; Adrian Marinovich; Kaveh Khoshnood; Kim M Blankenship; Sandra A Springer; Peter A Selwyn
Journal:  J Urban Health       Date:  2005-05-04       Impact factor: 3.671

2.  Clients' Satisfaction with Services for Prevention of Mother-to-Child Transmission of HIV in Public Health Facilities in Diredawa City, Eastern Ethiopia.

Authors:  Kinfe Abayneh; Bizatu Mengistie; Lemessa Oljira; Getahun Tiruye
Journal:  HIV AIDS (Auckl)       Date:  2020-10-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.